Avicanna Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was CAD 16.79 million compared to CAD 4.05 million a year ago. Net loss was CAD 8.74 million compared to CAD 14.74 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4 CAD | 0.00% |
|
+50.94% | +14.29% |
06-19 | US Patent and Trademark Office Issues Patent For Avicanna's SEDDS Technology | MT |
06-19 | Avicanna Brief: Announcing USPTO Issuance of Patent SEDDS Technology | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+14.29% | 28.6M | |
+38.65% | 39.1B | |
-8.62% | 38.76B | |
+26.95% | 31.24B | |
+10.74% | 25.9B | |
-13.50% | 25.8B | |
+44.87% | 14.06B | |
+34.36% | 13.12B | |
-7.14% | 11.32B | |
-12.61% | 10.68B |
- Stock Market
- Equities
- AVCN Stock
- News Avicanna Inc.
- Avicanna Inc. Reports Earnings Results for the Full Year Ended December 31, 2023